Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Helderman

Showing results (31-40 of 114) with videos related to

Pageof 12
Sort By:
Kidney International|May 9, 1998
Hepatitis C and renal transplantation: the controversy continuesS Goral, J H Helderman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 6, 2000
Is it time for ACE inhibitors in chronic allograft nephropathy?J B Lewis, J H Helderman
Seminars in Respiratory Infections|September 1, 1993
Immunosuppressive drugs and their effectsK R Superdock, J H Helderman
The Journal of Clinical Investigation|February 1, 1977
Emergence of insulin receptors upon alloimmune T cells in the ratJ H Helderman, T B Strom
Nature|July 6, 1978
Specific insulin binding site on T and B lymphocytes as a marker of cell activationJ H Helderman, T B Strom
Cellular Immunology|August 1, 1980
Comparison of ligand-specific rat allosensitized lymphocyte insulin receptors as assessed in binding and functional (lymphocyte-mediated cytotoxicity) assaysT B Strom, J H Helderman
Archives of Pathology|May 1, 1970
Heterologous serum-induced cellular alterations in the renal papilla. In vitro studiesJ H Helderman, J V Klavins
Transplantation Proceedings|March 26, 2004
Experience with cyclosporineA J Langone, J H Helderman
Proceedings of the Clinical Dialysis and Transplant Forum|November 19, 1976
The insulin receptor: a marker of T cell activation after allograftJ H Helderman, T B Strom
Experimental Cell Research|October 1, 1979
Absence of a role for the cellular exoskeleton in the emergence of the T lymphocyte insulin receptorJ H Helderman, T B Strom
Pageof 12

Showing results (31-40 of 114) with videos related to

Sort By:
Pageof 12
Kidney International|May 9, 1998
Hepatitis C and renal transplantation: the controversy continuesS Goral, J H Helderman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 6, 2000
Is it time for ACE inhibitors in chronic allograft nephropathy?J B Lewis, J H Helderman
Seminars in Respiratory Infections|September 1, 1993
Immunosuppressive drugs and their effectsK R Superdock, J H Helderman
The Journal of Clinical Investigation|February 1, 1977
Emergence of insulin receptors upon alloimmune T cells in the ratJ H Helderman, T B Strom
Nature|July 6, 1978
Specific insulin binding site on T and B lymphocytes as a marker of cell activationJ H Helderman, T B Strom
Cellular Immunology|August 1, 1980
Comparison of ligand-specific rat allosensitized lymphocyte insulin receptors as assessed in binding and functional (lymphocyte-mediated cytotoxicity) assaysT B Strom, J H Helderman
Archives of Pathology|May 1, 1970
Heterologous serum-induced cellular alterations in the renal papilla. In vitro studiesJ H Helderman, J V Klavins
Transplantation Proceedings|March 26, 2004
Experience with cyclosporineA J Langone, J H Helderman
Proceedings of the Clinical Dialysis and Transplant Forum|November 19, 1976
The insulin receptor: a marker of T cell activation after allograftJ H Helderman, T B Strom
Experimental Cell Research|October 1, 1979
Absence of a role for the cellular exoskeleton in the emergence of the T lymphocyte insulin receptorJ H Helderman, T B Strom
Pageof 12